Trials / Completed
CompletedNCT04477265
Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder
Efficacy of of Pelvic Floor Muscle Training( PFMT ) With Surface Electromyographic Biofeedback and Medication in Women With Overactive Bladder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Medical treatment for overactive bladder is acceptable widely. However, the effect of drug treatment is different due to compliance and side effect of the drug. Biofeedback-assisted pelvic floor muscle training (PFMT) is the first line recommendation for overactive bladder. The slow effect of biofeedback-assisted pelvic floor muscle training leads to low motivation for continuous treatment and results in compliance difference. This slow effect also changes the degree of improvement in the treatment of overactive bladder. This study is designed to evaluate the efficacy of combination therapy for treatment of female overactive bladder.
Detailed description
Participant will be prescribed with oral medication in combination with biofeedback-assisted pelvic floor muscle training (PFMT) for the first month. Participant will continue to have biofeedback assisted PFMT for another two months without oral medication. The investigators expected that combination therapy will improve the compliance and severity of symptoms in women with overactive bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solifenacin Succinate 5mg/tab daily | participants will be taking oral medication for 3 months |
| BEHAVIORAL | biofeedback-assisted pelvic floor muscle training | participants will be doing biofeedback-assisted pelvic floor muscle training for 3 months |
Timeline
- Start date
- 2016-06-16
- Primary completion
- 2021-12-24
- Completion
- 2021-12-24
- First posted
- 2020-07-20
- Last updated
- 2022-01-28
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04477265. Inclusion in this directory is not an endorsement.